Braun Stacey Associates Inc Reata Pharmaceuticals Inc Transaction History

Braun Stacey Associates Inc

  • $2.54 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
SELL
$79.22 - $105.37 $11.6 Million - $15.4 Million
-146,235 Reduced 47.02%
164,775 $16.8 Million
Q1 2023

May 08, 2023
BUY
$30.85 - $93.17 $9.59 Million - $29 Million
311,010 New
311,010 $28.3 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email